A Compassionate Use (CU) Program of Odronextamab

Clinical trial NCT05619367 · AVAILABLE

Trial details

NCT number: NCT05619367
Sponsor: Regeneron Pharmaceuticals
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Relapsed or Refractory (R/R) Follicular Lymphoma (FL)Diffuse Large B-Cell Lymphoma (DLBCL)B-Cell Non-Hodgkin Lymphoma (NHL)High-Grade B-Cell Lymphoma (HGBCL)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.